Our non-GLP biofluid tests provide robust, high-quality data for early-stage preclinical drug development. These services provide a rapid, cost-effective way to analyze blood and urine samples as a standalone service, or supplementary to in vivo studies.
Analytes listed in the following sections are subject to change. Please contact your local business development specialist for our current offerings. Additional assays are available with a validation lead time of approximately 2-3 weeks.
Gain valuable information about drug efficacy, candidate selection, MoA, and enzymatic activity using a comprehensive portfolio of clinical chemistry assays developed on the Beckman Coulter® AU480 Chemistry Analyzer and Sysmex BX-3010 Automatic Chemistry Analyzer.
Translational biomarkers are used throughout drug development to help elucidate underlying pathophysiology, understand an agents’ mechanism of action, measure efficacy, and stratify patient populations. We provide a panel of routinely performed immunoassay services to inform decision-making in drug development, as well as developing, validating, and performing custom assays.
Run your samples on MSD’s electrochemiluminescence technology platform. Using the Sector S 600, biomarkers can be customized into a V-PLEX or U-PLEX plate with up to 10 biomarkers of your choice.
Evaluate biomarkers on our standard, colorimetric, enzyme-based ELISA platform.
Turn Around Time: 5-7 business days (clinical chemistry), 7-10 business days (MSD & ELISA) Data Delivery Format: Excel File, unless otherwise requested
To ensure you receive reliable data, we perform rigorous quality control and assay qualification procedures to ensure precision and accuracy. Our high quality results enable you to make preclinical go/no-go decisions with confidence.
We are here to help!